We are live on ! Find out more
CNCE

Concert Pharmaceuticals, Inc.
CNCE

Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

67 hedge funds and large institutions have $178M invested in Concert Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

12% more capital invested

Capital invested by funds: $159M → $178M (+$18.9M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

1% less funds holding

Funds holding: 68 → 67 (-1)

Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.8%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
29
Reduced
13
Closed
17
Calls
$152K
Puts
–
Net Calls
+$152K
Net Calls Change
+$152K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$18M
2
SAM
Senzar Asset Management
New York
+$6.72M
3
BFA
BlackRock Fund Advisors
California
+$6.69M
4
Millennium Management
Millennium Management
New York
+$2.94M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$1.85M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$5.47M
2
QF
QVT Financial
New York
-$3.94M
3
ACPU
Arrowgrass Capital Partners (US)
Delaware
-$2.23M
4
Jennison Associates
Jennison Associates
New York
-$2.22M
5
EAM
EverPoint Asset Management
Connecticut
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$816K -$1.18M -77,216 -58%
BIM
27
BlackRock Investment Management
Delaware
$809K +$807K +52,996 +3,949%
GPCM
28
Granite Point Capital Management
Massachusetts
$779K -$1.18M -77,669 -60%
TC
29
TFS Capital
Pennsylvania
$767K +$246K +16,129 +46%
Northern Trust
30
Northern Trust
Illinois
$731K +$451K +29,599 +152%
BCM
31
Bridgeway Capital Management
Texas
$648K – – –
AQR Capital Management
32
AQR Capital Management
Connecticut
$469K +$480K +31,499 New
BCM
33
Bourgeon Capital Management
Connecticut
$447K +$457K +30,000 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$418K +$428K +28,090 New
CS
35
Credit Suisse
Switzerland
$404K -$557K -36,582 -57%
Goldman Sachs
36
Goldman Sachs
New York
$401K +$27.9K +1,832 +7%
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$401K +$28.9K +1,900 +8%
IAM
38
Iridian Asset Management
Connecticut
$363K +$206K +13,542 +125%
TA
39
Teachers Advisors
New York
$332K +$339K +22,268 New
Charles Schwab
40
Charles Schwab
California
$324K +$331K +21,722 New
FWM
41
Frontier Wealth Management
Missouri
$318K +$325K +21,330 New
ProShare Advisors
42
ProShare Advisors
Maryland
$287K +$70.7K +4,643 +32%
PAM
43
Panagora Asset Management
Massachusetts
$283K -$208K -13,655 -42%
VKH
44
Virtu KCG Holdings
New York
$282K +$288K +18,935 New
TCIM
45
TIAA CREF Investment Management
New York
$240K +$245K +16,093 New
SFM
46
Sphera Funds Management
Israel
$236K -$5.47M -359,142 -96%
SKK
47
Shepherd Kaplan Krochuk
Massachusetts
$223K – – –
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$196K +$201K +13,180 New
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$176K +$180K +11,833 New
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$156K +$16.8K +1,100 +12%
1
2
3 4

CNCE Hedge Fund Activity: Q2 2015 in Review

67 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Concert Pharmaceuticals, Inc. (CNCE) for Q2 2015, worth a combined $178M — up 12% from $159M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CNCE and 16 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 29 added.

The largest buyer was BVF Inc, adding an estimated $18M. The largest seller was Sphera Funds Management, cutting an estimated $5.47M.

  • 67 institutional investors held Concert Pharmaceuticals, Inc. (CNCE) as of Q2 2015, down from 68 in Q1 2015.
  • Funds reported $178M of Concert Pharmaceuticals, Inc. stock for Q2 2015, up 12% quarter-over-quarter.
  • 16 funds opened new Concert Pharmaceuticals, Inc. positions in Q2 2015 and 17 closed out, a net change of -1 holder.
  • The largest Concert Pharmaceuticals, Inc. buyer in Q2 2015 was BVF Inc, an estimated $18M added.
  • The largest Concert Pharmaceuticals, Inc. seller in Q2 2015 was Sphera Funds Management, an estimated $5.47M sold.

Based on aggregated 13F filings for Q2 2015.